SCHEMBL25919802

SCHEMBL25919802

COCCN1C(=O)C(=O)c2cc(OC)cc(OC)c21

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARK7 Q99497 3/20 0.49
ALDH1A1 P00352 10/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
KDM4E B2RXH2 1/20 0.45
MAPT P10636 5/20 0.44
KMT2A Q03164 4/20 0.44
MEN1 O00255 3/20 0.44
LMNA P02545 2/20 0.44
L3MBTL1 Q9Y468 3/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
CHRM5 P08912 2/20 0.42
MAPK1 P28482 1/20 0.41
ELANE P08246 1/20 0.39
HPGD P15428 1/20 0.38
ALOX15 P16050 1/20 0.38
TSHR P16473 1/20 0.38
ALOX12 P18054 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
HSD17B10 Q99714 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25919801 0.79 ALDH1A1 (0.56) PARK7ALDH1A1CYP1A2CYP3A4KDM4E
SCHEMBL25327936 0.74 ALDH1A1 (0.51) ALDH1A1CYP1A2CYP3A4KDM4EMAPT
SCHEMBL3023083 0.72 PARK7 (0.53) PARK7ALDH1A1MAPTKMT2AMEN1
SCHEMBL9393324 0.71 ALDH1A1 (0.58) PARK7ALDH1A1CYP1A2CYP3A4KDM4E
SCHEMBL18955214 0.68 L3MBTL1 (0.57) PARK7ALDH1A1CYP1A2CYP3A4KDM4E
SCHEMBL25919805 0.67 CES1 (0.40) ALDH1A1KDM4ELMNACHRM5TDP1
SCHEMBL16226679 0.66 ALDH1A1 (1.00) ALDH1A1CYP1A2CYP3A4KDM4EMAPT
SCHEMBL12930189 0.65 CES1 (0.71) PARK7ALDH1A1
SCHEMBL2307148 0.65 MGLL (0.40) PARK7ALDH1A1KDM4EMAPTKMT2A
SCHEMBL31544423 0.64 MGLL (0.50) ALDH1A1CYP1A2CYP3A4KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230327205-A1 ISATIN DERIVATIVE REDOXAMER FOR ELECTROCHEMICAL DEVICE UCHICAGO ARGONNE, LLC. (US) 2023-10-12 US disclosed
US-20230327205-A1 ISATIN DERIVATIVE REDOXAMER FOR ELECTROCHEMICAL DEVICE UCHICAGO ARGONNE, LLC. (US) 2023-10-12 US disclosed
US-11715844-B2 Isatin derivative redoxmer for electrochemical device UCHICAGO ARGONNE, LLC (US) 2023-08-01 US disclosed
US-11715844-B2 Isatin derivative redoxmer for electrochemical device UCHICAGO ARGONNE, LLC (US) 2023-08-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230327205-A1 ISATIN DERIVATIVE REDOXAMER FOR ELECTROCHEMICAL DEVICE NDUFS5, SQOR, NDUFS7 PARK7 634/4885ALDH1A1 1221/4885CYP1A2 1978/4885
US-11715844-B2 Isatin derivative redoxmer for electrochemical device SQOR, SLC39A14, NDUFS5 PARK7 908/4885ALDH1A1 630/4885CYP1A2 1508/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.